NCT01810003View on ClinicalTrials.gov

Impact of EPA and DHA Supplementation on Plasma Biomarkers of Inflammation (n3)

NACompletedINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

July 31, 2015

Study Completion Date

December 31, 2017

Conditions
Cardiovascular Disease, Inflammation
Interventions
DIETARY_SUPPLEMENT

High DHA

10 week supplementation period

DIETARY_SUPPLEMENT

High EPA

10 week supplementation period

DIETARY_SUPPLEMENT

Placebo

10 week supplementation period

Trial Locations (1)

G1V 0A6

Institute of Nutrition and Functional Foods (INAF), Laval University, Québec

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

Laval University

OTHER

NCT01810003 - Impact of EPA and DHA Supplementation on Plasma Biomarkers of Inflammation (n3) | Biotech Hunter | Biotech Hunter